ALLAKOS INC's ticker is ALLK and the CUSIP is 01671P100. A total of 134 filers reported holding ALLAKOS INC in Q1 2022. The put-call ratio across all filers is 0.60 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $2,733,000 | -90.1% | 279,155 | +7.2% | 0.00% | -83.3% |
| Q3 2021 | $27,573,000 | +71.4% | 260,442 | +38.2% | 0.01% | +100.0% |
| Q2 2021 | $16,083,000 | +4.4% | 188,389 | +40.4% | 0.00% | -25.0% |
| Q1 2021 | $15,406,000 | -61.2% | 134,225 | -52.7% | 0.00% | -55.6% |
| Q4 2020 | $39,718,000 | +66.1% | 283,701 | -3.3% | 0.01% | +50.0% |
| Q3 2020 | $23,907,000 | +8.4% | 293,519 | -4.4% | 0.01% | 0.0% |
| Q2 2020 | $22,058,000 | +168.3% | 306,952 | +66.1% | 0.01% | +100.0% |
| Q1 2020 | $8,220,000 | +422.6% | 184,770 | +823.8% | 0.00% | – |
| Q3 2019 | $1,573,000 | +81.4% | 20,000 | 0.0% | 0.00% | – |
| Q2 2019 | $867,000 | +7.0% | 20,000 | 0.0% | 0.00% | – |
| Q1 2019 | $810,000 | -22.5% | 20,000 | 0.0% | 0.00% | – |
| Q4 2018 | $1,045,000 | +16.1% | 20,000 | 0.0% | 0.00% | – |
| Q3 2018 | $900,000 | – | 20,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 270,965 | $12,055,000 | 6.94% |
| NEA Management Company, LLC | 2,268,188 | $100,912,000 | 5.27% |
| Fairmount Funds Management LLC | 178,662 | $7,949,000 | 4.82% |
| Redmile Group, LLC | 2,976,928 | $132,444,000 | 3.71% |
| Boxer Capital, LLC | 675,000 | $30,031,000 | 2.05% |
| Rock Springs Capital Management LP | 235,000 | $10,455,000 | 0.43% |
| Cormorant Asset Management, LP | 200,000 | $8,898,000 | 0.41% |
| RAMIUS ADVISORS LLC | 31,155 | $1,386,000 | 0.35% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 15,700 | $692,000 | 0.32% |
| Handelsinvest Investeringsforvaltning | 20,000 | $890,000 | 0.24% |